News

To date many products have been available in Germany on a ‘named patient’ basis, however, as a result of the TAV all immunotherapy products containing common allergens (grass,

Cipla said that the ‘Mother-Baby Pack’ has been developed in line with the latest World Health Organisation (WHO) guidelines on Prevention of Mother-to-Child Transmission (PMTCT) Option A .

The newly funded research project will focus on the impact of Davunetide on a key pathology in PD, namely alpha-synuclein. Allon said that a previous preclinical project, also

The paper, ‘A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia,’ published in the Journal of Antimicrobial Chemotherapy, provides an overview of the treatment of a single

The platform’s Protein Chain Reaction allows for screening against cell surface targets in their native state on live cells or purified target proteins. X-BODY claims that its platform

Aricept (donepezil HCl) is a prescription medicine to treat mild, moderate and severe alzheimer’s disease. Ranbaxy Pharmaceuticals Trade Sales vice president Bill Winter said that they are pleased

Icagen and Pfizer have recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7. They have now selected one of

According to the studies in preclinical models of alzheimer’s disease, ELND005 is believed to inhibit the aggregation (clumping) of amyloid-beta proteins in the brain thereby neutralising the toxic

The CellCiphr cytotoxicity panels detect toxicological markers in a range of cell models (HepG2, primary hepatocytes and cardiomyocytes). The CellCiphr technology applies High Content Screening (HCS) technology to